These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25152111)

  • 21. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of KIR/HLA receptor-ligand mode on prognosis of single unrelated cord blood transplantation in patients with hematological malignancies].
    Fang TT; Zhu XY; Tang BL; Liu HL; Wan X; Song KD; Yao W; Sun GY; Fang XC; Sun ZM
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):204-209. PubMed ID: 32311889
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.
    Barker JN; Scaradavou A; Stevens CE
    Blood; 2010 Mar; 115(9):1843-9. PubMed ID: 20029048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
    Gluckman E; Rocha V; Arcese W; Michel G; Sanz G; Chan KW; Takahashi TA; Ortega J; Filipovich A; Locatelli F; Asano S; Fagioli F; Vowels M; Sirvent A; Laporte JP; Tiedemann K; Amadori S; Abecassis M; Bordigoni P; Diez B; Shaw PJ; Vora A; Caniglia M; Garnier F; Ionescu I; Garcia J; Koegler G; Rebulla P; Chevret S;
    Exp Hematol; 2004 Apr; 32(4):397-407. PubMed ID: 15050751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.
    Kanda J; Ichinohe T; Kato S; Uchida N; Terakura S; Fukuda T; Hidaka M; Ueda Y; Kondo T; Taniguchi S; Takahashi S; Nagamura-Inoue T; Tanaka J; Atsuta Y; Miyamura K; Kanda Y;
    Leukemia; 2013 Feb; 27(2):286-94. PubMed ID: 22806066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The efficacy and safety of unmanipulated haploidentical peripheral blood stem cell transplantation on hematologic diseases].
    Huang WR; Li HH; Jin XS; Wang SH; Bo J; Zhao Y; Jing Y; Zhu HY; Dou LP; Jia BJ; Wang QS; Gao CJ; Yu L
    Zhonghua Nei Ke Za Zhi; 2013 May; 52(5):390-4. PubMed ID: 23945304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvaged single-unit cord blood transplantation for 26 patients with hematologic malignancies not in remission.
    Yao W; Zheng CC; Liu HL; Geng LQ; Tang BL; Tong J; Zhu XY; Song KD; Qiang P; Sun ZM
    Braz J Med Biol Res; 2015 Oct; 48(10):871-6. PubMed ID: 26445329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignancies.
    Moscardó F; Sanz J; Carbonell F; Sanz MA; Larrea L; Montesinos P; Lorenzo I; Vera B; Boluda B; Salazar C; Cañigral C; Planelles D; Jarque I; Solves P; Martín G; López F; de la Rubia J; Martínez J; Carpio N; Martínez-Cuadrón D; Puig N; Montoro JA; Roig R; Sanz GF
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1744-50. PubMed ID: 25008329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.
    Le Bourgeois A; Labopin M; Guillaume T; Delaunay J; Foucher Y; Tessoulin B; Malard F; Ayari S; Peterlin P; Derenne S; Herry P; Cesbron A; Gagne K; Lodé L; Illiaquer M; Imbert-Marcille BM; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Exp Hematol; 2014 Nov; 42(11):945-54. PubMed ID: 25072620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Umbilical cord blood transplantation in hematologic diseases in patients over 15 years old: long-term experience at the Pontificia Universidad Católica de Chile.
    Ramirez P; Nervi B; Bertin P; Poggi H; Lagos M; Selman C; Pizarro I; Jara V; Wiestruck A; Barriga F
    Transplant Proc; 2013; 45(10):3734-9. PubMed ID: 24315012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].
    ZHANG Y; CHEN YK; FAN ZP; XU D; JIANG QL; SUN J; LIU QF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):438-42. PubMed ID: 21421478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
    Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies.
    Huang W; Li H; Gao C; Bo J; Wang Q; Zhao Y; Jing Y; Wang S; Zhu H; Dou L; Wang L; Yu L
    Transfusion; 2012 Jun; 52(6):1354-62. PubMed ID: 22233440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.